Bain Capital Public Equity Management II’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
N
PC
ACA
Bain Capital Public Equity Management II's HZNP Position: Q3 2022 in Review
Bain Capital Public Equity Management II sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 343,152 shares — an estimated $27.4M sold.
Bain Capital Public Equity Management II first reported a position in HZNP in Q3 2019 and held it in 10 quarters. The position peaked at $135M in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.
- Bain Capital Public Equity Management II reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
- Bain Capital Public Equity Management II sold 343,152 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $27.4M.
- Bain Capital Public Equity Management II first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 10 quarters.
- Bain Capital Public Equity Management II's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $135M in Q1 2022.
- 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.
Based on Bain Capital Public Equity Management II's 13F filing for Q3 2022, filed 14 Nov 2022.